Poland· PL-100507810
Tauvid
A flortaucipir (18f) product containing flortaucipirum (18f), registered in Poland by Eli Lilly Nederland B.V.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Flortaucipir (18f) is registered in 7 of 19 countries.
Countries holding a registration under ATC V09AX07 (flortaucipir (18f)), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Flortaucipir (18f) · ATC V09AX07
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Flortaucipirum (18F)
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Poland (PL)
- ATC code
- V09AX07
- ATC class
- Flortaucipir (18F)
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09AX07
Flortaucipir (18f), as other registers publish it.
- FinlandTauvidEli Lilly Nederland B.V
- FinlandTauvidEli Lilly Nederland B.V
- PolandTauvidEli Lilly Nederland B.V.
- IcelandTauvidEli Lilly Nederland B.V.*
- IcelandTauvidEli Lilly Nederland B.V.*
- CzechiaTAUVIDEli Lilly Nederland B.V., Utrecht
- CzechiaTAUVIDEli Lilly Nederland B.V., Utrecht
- NetherlandsTauvid 1.900 MBq/ml oplossing voor injectieEli Lilly Nederland B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/606bb057-6b9d-4653-a07f-724f2ae3a4c5 GET /v1/drugs/606bb057-6b9d-4653-a07f-724f2ae3a4c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "1900 MBq/ml",
"packaging": "Rpz ¦ EU/1/24/1799/002 ¦ 158798\n1 fiol. 1,0 - 15 ml",
"substance": "Flortaucipirum (18F) 1900 MBq/ml",
"common_name": "Flortaucipirum (18F)",
"pl_product_id": "100507810",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about flortaucipir (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.